Fineline Cube

Follow:
14778 Articles
We Doctor Holdings Limited Files for IPO on Hong Kong Stock Exchange
CompanyDeals

We Doctor Holdings Limited Files for IPO on Hong Kong Stock Exchange

Shinva Medical Instrument to Acquire Stake in Wuhan Zhongzhi Biotechnologies for IVD Expansion
CompanyDeals

Shinva Medical Instrument to Acquire Stake in Wuhan Zhongzhi Biotechnologies for IVD Expansion

Hinova Pharmaceuticals' HP568 Earns FDA Clinical Trial Approval for ER+/HER2- Breast Cancer
CompanyDrug

Hinova Pharmaceuticals’ HP568 Earns FDA Clinical Trial Approval for ER+/HER2- Breast Cancer

CanSino Biologics' Menhycia Receives Market Approval in Indonesia
CompanyDrug

CanSino Biologics’ Menhycia Receives Market Approval in Indonesia

CSPC Pharmaceutical Group Receives NMPA Approval for SYH9016 Clinical Study in Solid Tumors
CompanyDrug

CSPC Pharmaceutical Group Receives NMPA Approval for SYH9016 Clinical Study in Solid Tumors

MicuRx Pharmaceuticals' MRX-5 Receives FDA Orphan Drug Designation for NTM Infections
CompanyDrug

MicuRx Pharmaceuticals’ MRX-5 Receives FDA Orphan Drug Designation for NTM Infections

Hengrui Pharmaceuticals and IDEAYA Biosciences Ink Licensing Deal for SHR-4849
CompanyDeals

Hengrui Pharmaceuticals and IDEAYA Biosciences Ink Licensing Deal for SHR-4849

CARsgen Therapeutics' Satricabtagene Autoleucel Shows Positive Results in Phase II Study
CompanyDrug

CARsgen Therapeutics’ Satricabtagene Autoleucel Shows Positive Results in Phase II Study

argenx's Vygart Hytrulo Approved in Japan for Chronic Inflammatory Demyelinating Polyneuropathy
CompanyDrug

argenx’s Vygart Hytrulo Approved in Japan for Chronic Inflammatory Demyelinating Polyneuropathy

Daiichi Sankyo's Datroway Approved in Japan for HR+, HER2- Breast Cancer
CompanyDrug

Daiichi Sankyo’s Datroway Approved in Japan for HR+, HER2- Breast Cancer

MabPharm's CMAB807 Biosimilar Receives Market Approval in Indonesia and Peru
CompanyDrug

MabPharm’s CMAB807 Biosimilar Receives Market Approval in Indonesia and Peru

Shanghai Ark Biopharmaceutical Partners with Partex to Advance AI-Driven Drug Development
CompanyDeals

Shanghai Ark Biopharmaceutical Partners with Partex to Advance AI-Driven Drug Development